<DOC>
	<DOCNO>NCT02044068</DOCNO>
	<brief_summary>Vertical HIV transmission dramatically reduce use combine antiretroviral therapy HIV-infected pregnant woman . Among often use drug , several dual activity , HIV HBV : lamivudine , emtricitabine , tenofovir . Studies vertical HBV transmission HIV-HBV co-infected pregnant woman rare developed country . The study hypothesis major reduction risk HBV vertical transmission .</brief_summary>
	<brief_title>Hepatitis B Virus Vertical Transmission From HIV-HBV Co-infected Women</brief_title>
	<detailed_description>Mother-to-Child HIV transmission dramatically reduce use combine antiretroviral therapy HIV-infected pregnant woman , develop develop country . Among often use drug , several dual activity , HIV HBV : lamivudine , emtricitabine , tenofovir ; use combo , tenofovir+emtricitabine instance . Studies vertical HBV transmission HIV-HBV co-infected pregnant woman rare developed country . The study hypothesis major reduction risk HBV vertical transmission context , justify retrospective study .</detailed_description>
	<mesh_term>Hepatitis B</mesh_term>
	<criteria>child bear Maternity Department HIVHBV coinfected woman whose mother give treatment dual activity ( HIV HBV ) pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>9 Months</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>